Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib

被引：0
|
作者：
Fan Wu
Gopal Krishna
Sekhar Surapaneni
机构：
[1] Bristol Myers Squibb,Nonclinical Research and Development
[2] Bristol Myers Squibb,Clinical Pharmacology
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词：
Drug–drug interaction; PBPK; Metabolic inhibition; Simcyp; Fedratinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：461 / 473
页数：12
相关论文
共 50 条
  • [1] Physiologically based pharmacokinetic modeling to assess metabolic drug-drug interaction risks and inform the drug label for fedratinib
    Wu, Fan
    Krishna, Gopal
    Surapaneni, Sekhar
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (04) : 461 - 473
  • [2] Prediction of drug–drug interaction potential using physiologically based pharmacokinetic modeling
    Jee Sun Min
    Soo Kyung Bae
    Archives of Pharmacal Research, 2017, 40 : 1356 - 1379
  • [3] Physiologically based pharmacokinetic modeling for assessing the clinical drug-drug interaction of alisporivir
    Xia, Binfeng
    Barve, Avantika
    Heimbach, Tycho
    Zhang, Tao
    Gu, Helen
    Wang, Lai
    Einolf, Heidi
    Alexander, Natalya
    Hanna, Imad
    Ke, June
    Mangold, James B.
    He, Handan
    Sunkara, Gangadhar
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 63 : 103 - 112
  • [4] Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling
    Min, Jee Sun
    Bae, Soo Kyung
    ARCHIVES OF PHARMACAL RESEARCH, 2017, 40 (12) : 1356 - 1379
  • [5] Use of Physiologically-Based Pharmacokinetic (PBPK) Modeling to Assess Drug Interaction Potential of Antibody-Drug Conjugates (ADCs)
    Samineni, Divya
    Chen, Yuan
    Mukadam, Sophie
    Wong, Harvey
    Shen, Ben-Quan
    Lu, Dan
    Hop, Cornelis
    Girish, Sandhya
    Li, Chunze
    Jin, Jin Yan
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S91 - S91
  • [6] Evaluation of drug-drug interaction potential for pemigatinib using physiologically based pharmacokinetic modeling
    Ji, Tao
    Chen, Xuejun
    Yeleswaram, Swamy
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (07): : 894 - 905
  • [7] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING FOR ASSESSMENT OF THE DRUG-DRUG INTERACTION POTENTIAL OF ZAVEGEPANT
    Ke, A.
    Callegari, E.
    Bhardwaj, R.
    Varma, M.
    Muto, C.
    Bertz, R.
    Sahasrabudhe, V.
    Liu, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S107 - S107
  • [8] Simulation and Prediction of the Drug-Drug Interaction Potential of Naloxegol by Physiologically Based Pharmacokinetic Modeling
    Zhou, D.
    Bui, K.
    Sostek, M.
    Al-Huniti, N.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (05): : 250 - 257
  • [9] Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug–Drug Interaction Potentials
    Su-jin Rhee
    Hyun A. Lee
    Soyoung Lee
    Eunwoo Kim
    Inseung Jeon
    Im-Sook Song
    Kyung-Sang Yu
    Pharmaceutical Research, 2018, 35
  • [10] Physiologically Based Pharmacokinetic Modeling for Maribavir to Inform Dosing in Drug-Drug Interaction Scenarios with CYP3A4 Inducers and Inhibitors
    Chen, Grace
    Sun, Kefeng
    Michon, Ingrid
    Barter, Zoe
    Neuhoff, Sibylle
    Ghosh, Lipika
    Ilic, Katarina
    Song, Ivy H.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (05): : 590 - 600
12345